We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Digital Voice Analysis in Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00524979
Recruitment Status : Completed
First Posted : September 5, 2007
Last Update Posted : May 16, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
There is a differences in voice frequency of schizophrenic patients compared to patients with other mental diseases and compared to mentally healthy people.

Condition or disease
Schizophrenia

Study Design

Study Type : Observational
Actual Enrollment : 60 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Digital Voice Analysis in Patients With Schizophrenia
Study Start Date : October 2007
Study Completion Date : November 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Schizophrenia
People who are diagnosed as schizophrenic by DSM-IV
Mental diseases
Patients who are deagnosed as having mental disease other then schizophrenia
Mentally healthy
People who have no mental disease


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
  • Schizophrenic patients
  • Other mental disease patients
  • Healthy people
Criteria

Inclusion Criteria:

  • Schizophrenic patients
  • Other mental disease patients
  • Healthy people
  • People above age 18

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00524979


Locations
Israel
Beer Yaakov MHC
Beer Yaakov, Israel, 70350
Sponsors and Collaborators
BeerYaakov Mental Health Center
Investigators
Principal Investigator: Ilana Vaintraub, MD Beer Yaakov Mental Health Center
More Information

Responsible Party: Ilana Vaintrayb, MD, BeerYaakov Mental Health Center
ClinicalTrials.gov Identifier: NCT00524979     History of Changes
Other Study ID Numbers: Voice -200CTIL
First Posted: September 5, 2007    Key Record Dates
Last Update Posted: May 16, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders